Sarraf Pasha
SEC insider (Form 3/4/5 filer). CIK 0002059447. Director at Cue Biopharma, Inc. (CUE). 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in BOSTON, MA.
Companies Sarraf Pasha has filed insider reports for
- Cue Biopharma, Inc. (CUE): Director
Sarraf Pasha
CIK: 0002059447
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cue Biopharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 9, 2026CUE
Cue Biopharma, Inc.
AwardDirect18.4K shares- - Jul 9, 2026CUE
Cue Biopharma, Inc.
AwardDirect21.8K shares- - Jan 2, 2026CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
24.4K shares- - Dec 30, 2025CUE
Cue Biopharma, Inc.
PurchaseDirect78.1K shares at avg. $0.31$24K - Dec 30, 2025CUE
Cue Biopharma, Inc.
PurchaseDirect4.2K shares at avg. $0.31$1K - Dec 30, 2025CUE
Cue Biopharma, Inc.
PurchaseDirect77.4K shares at avg. $0.30$23K - Dec 30, 2025CUE
Cue Biopharma, Inc.
PurchaseDirect77.1K shares at avg. $0.30$23K - Dec 30, 2025CUE
Cue Biopharma, Inc.
PurchaseDirect86.9K shares at avg. $0.32$28K - Mar 10, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
48.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | CUE Cue Biopharma, Inc. | Award | 18,400 | - | $0 | Direct |
| Jul 9, 2026 | CUE Cue Biopharma, Inc. | Award | 21,800 | - | $0 | Direct |
| Jan 2, 2026 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 24,400 | - | - | Direct |
| Dec 30, 2025 | CUE Cue Biopharma, Inc. | Purchase | 78,116 | $0.31 | $24,325 | Direct |
| Dec 30, 2025 | CUE Cue Biopharma, Inc. | Purchase | 4,229 | $0.31 | $1,308 | Direct |
| Dec 30, 2025 | CUE Cue Biopharma, Inc. | Purchase | 77,417 | $0.30 | $23,349 | Direct |
| Dec 30, 2025 | CUE Cue Biopharma, Inc. | Purchase | 77,148 | $0.30 | $23,168 | Direct |
| Dec 30, 2025 | CUE Cue Biopharma, Inc. | Purchase | 86,947 | $0.32 | $27,597 | Direct |
| Mar 10, 2025 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 48,800 | - | - | Direct |
1-9 of 9 transactions